Livzon Pharmaceutical Group Inc. provides preliminary earnings guidance for the full year ending December 31, 2018. For the period, the company net profit attributable to the shareholders of the listed company approximately to be RMB 1,127.51 million to RMB 1,250.5134 million, decreased by approximately 71.76% to 74.54% as compared to the corresponding period last year. Basic earnings per share to be approximately RMB 1.57 to­ RMB 1.74 per share.